BIOMARKER:

EGFR exon 19 deletion + KRAS mutation

Entrez ID:

Related biomarkers:

‹

›

EGFR exon 19 deletion + KRAS mutation EGFR exon 19 deletion + KRAS mutation	Non Small Cell Lung Cancer NSCLC	EGFR exon 19 deletion + KRAS mutation EGFR exon 19 deletion + KRAS mutation	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C3 – Early Trials	erlotinib Sensitive: C3 – Early Trials
EGFR exon 19 deletion + KRAS mutation EGFR exon 19 deletion + KRAS mutation	Non Small Cell Lung Cancer NSCLC	EGFR exon 19 deletion + KRAS mutation EGFR exon 19 deletion + KRAS mutation	Non Small Cell Lung Cancer NSCLC	gefitinib Sensitive: C3 – Early Trials	gefitinib Sensitive: C3 – Early Trials

Associations